No Data
No Data
Express News | Candel Therapeutics will join the Russell 3000 index.
Express News | Candel Therapeutics to Join Russell 3000® Index
Candel Therapeutics to Join Russell 3000 Index
NEEDHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biolog
Retail Investors Among Candel Therapeutics, Inc.'s (NASDAQ:CADL) Largest Stockholders and Were Hit After Last Week's 20% Price Drop
Key Insights Candel Therapeutics' significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public 48% of the business is held by the top
12 Health Care Stocks Moving In Monday's After-Market Session
GainersFibroGen (NASDAQ:FGEN) stock moved upwards by 24.4% to $1.53 during Monday's after-market session. The market value of their outstanding shares is at $152.1 million. Candel Therapeutics (NASDAQ
Candel Therapeutics shares rose 3.4% after the U.S. Food and Drug Administration provided an orphan drug label for the company's glioma treatment
Candel Therapeutics shares rose 3.4% after the U.S. Food and Drug Administration provided an orphan drug label for the company's glioma treatment
No Data